ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
BridgeBio Oncology Therapeutics, Inc
9.25
+0.5300
6.08%
盘后:
9.25
0.0000
0.00%
16:10 EDT
成交量:
9.78万
成交额:
90.43万
市值:
7.40亿
市盈率:
-5.52
高:
9.39
开:
8.86
低:
8.86
收:
8.72
52周最高:
14.87
52周最低:
8.50
股本:
7,998.87万
流通股本:
4,460.40万
量比:
0.73
换手率:
0.22%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.6760
每股收益(LYR):
-4.3039
净资产收益率:
-48.23%
总资产收益率:
-29.75%
市净率:
1.80
市盈率(LYR):
-2.15
数据加载中...
总览
公司
新闻资讯
公告
Bridgebio Oncology Therapeutics, Inc.盘中异动 下午盘股价大涨5.11%
市场透视
·
02/19
美国研究综述-KKR、Sirius XM、Workday
路透中文
·
02/10
Bridgebio Oncology Therapeutics, Inc.盘中异动 急速下挫5.01%
市场透视
·
02/05
Bridgebio Oncology Therapeutics, Inc.盘中异动 大幅跳水5.76%
市场透视
·
01/14
Bridgebio Oncology Therapeutics, Inc.盘中异动 股价大涨5.08%报13.98美元
市场透视
·
01/09
BridgeBio Oncology Therapeutics公布三项创新Ras与Pi3kΑ研发项目临床数据取得新突破
美股速递
·
01/07
Bbot在圣安东尼奥乳腺癌研讨会上发布关于Bbo-10203的最新预临床数据,这是一款首创的Ras:Pi3kΑ抑制剂
美股速递
·
2025/12/11
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BBOT/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":9.25,"timestamp":1774468800000,"preClose":8.72,"halted":0,"volume":97779,"hourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.25,"latestTime":"16:10 EDT","volume":436,"amount":4033,"timestamp":1774469405012,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06077981651376139,"floatShares":44603977,"shares":79988687,"eps":-1.676,"marketStatus":"盘后交易","change":0.53,"latestTime":"03-25 16:27:59 EDT","open":8.86,"high":9.39,"low":8.86,"amount":904312.270666,"amplitude":0.06078,"askPrice":10,"askSize":8,"bidPrice":7,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.676,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":4,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":8.72,"postHourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.25,"latestTime":"16:10 EDT","volume":436,"amount":4033,"timestamp":1774469405012,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.733223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":44603977,"roa":"-29.75%","roe":"-48.23%","lyrEps":-4.3039,"volumeRatio":0.733223,"shares":79988687,"dividePrice":0,"high":9.39,"amplitude":0.06078,"preClose":8.72,"low":8.86,"week52Low":8.5,"pbRate":"1.80","week52High":14.87,"institutionHeld":0,"latestPrice":9.25,"committee":0.111111,"eps":-1.676,"divideRate":0,"volume":97779,"delay":0,"ttmEps":-1.676,"open":8.86,"prevYearClose":12.52,"prevWeekClose":8.68,"prevMonthClose":10.03,"prevQuarterClose":12.52,"fiveDayClose":8.88,"twentyDayClose":10.3,"sixtyDayClose":12.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"BBOT","fiscalQuarterEnding":"2025/12","expectedEps":-0.67,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-12","symbol":"BBOT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1770782400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2026-03-24","current":-5.519093,"percent":0.993289,"low":-11.944957,"twenty":-10.517006,"median":-8.800328,"eighty":-7.80442,"high":-5.182514,"avg":-8.954189,"sd":1.62433,"marketCap":705089170},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-17","current":-10.3182,"twenty":-11.192532,"median":-10.372506,"eighty":-9.601414,"marketCap":902842494},{"date":"2025-10-24","current":-9.838494,"twenty":-11.156298,"median":-10.223893,"eighty":-9.601414,"marketCap":860868237},{"date":"2025-10-31","current":-10.861263,"twenty":-11.08659,"median":-10.23674,"eighty":-9.656742,"marketCap":950360520},{"date":"2025-11-07","current":-11.087539,"twenty":-11.118284,"median":-10.345353,"eighty":-9.745662,"marketCap":970159697},{"date":"2025-11-14","current":-11.205203,"twenty":-11.201583,"median":-10.472068,"eighty":-9.804136,"marketCap":980455269},{"date":"2025-11-21","current":-8.47671,"twenty":-11.192532,"median":-10.345353,"eighty":-9.572151,"marketCap":974262207},{"date":"2025-11-28","current":-8.567184,"twenty":-11.17443,"median":-10.251046,"eighty":-9.478901,"marketCap":984660736},{"date":"2025-12-05","current":-8.0313,"twenty":-11.121014,"median":-10.182434,"eighty":-9.298176,"marketCap":923069447},{"date":"2025-12-12","current":-8.936039,"twenty":-11.105583,"median":-10.084778,"eighty":-9.061365,"marketCap":1027054741},{"date":"2025-12-19","current":-8.389716,"twenty":-11.080298,"median":-9.97426,"eighty":-8.826299,"marketCap":964263621},{"date":"2025-12-26","current":-8.490629,"twenty":-11.051335,"median":-9.938056,"eighty":-8.720294,"marketCap":975861981},{"date":"2026-01-02","current":-8.713334,"twenty":-11.00789,"median":-9.919954,"eighty":-8.650698,"marketCap":1001458361},{"date":"2026-01-09","current":-9.256178,"twenty":-10.960825,"median":-9.809862,"eighty":-8.597806,"marketCap":1063849537},{"date":"2026-01-16","current":-8.003462,"twenty":-10.901088,"median":-9.61327,"eighty":-8.567184,"marketCap":919869900},{"date":"2026-01-23","current":-7.829474,"twenty":-10.885701,"median":-9.557912,"eighty":-8.530995,"marketCap":899872728},{"date":"2026-01-30","current":-8.699415,"twenty":-10.880305,"median":-9.521034,"eighty":-8.553265,"marketCap":999858587},{"date":"2026-02-06","current":-7.063925,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"marketCap":811885173},{"date":"2026-02-13","current":-7.947786,"twenty":-10.83411,"median":-9.398729,"eighty":-8.38554,"marketCap":913470805},{"date":"2026-02-20","current":-7.043047,"twenty":-10.812388,"median":-9.272371,"eighty":-8.35979,"marketCap":809485512},{"date":"2026-02-27","current":-7.13352,"twenty":-10.763512,"median":-9.179623,"eighty":-8.144045,"marketCap":819884041},{"date":"2026-03-06","current":-6.882977,"twenty":-10.695084,"median":-9.036987,"eighty":-8.006246,"marketCap":791088114},{"date":"2026-03-13","current":-5.451193,"twenty":-10.678337,"median":-8.936039,"eighty":-7.945698,"marketCap":730699673},{"date":"2026-03-20","current":-5.403428,"twenty":-10.588779,"median":-8.821207,"eighty":-7.854528,"marketCap":724297048},{"date":"2026-03-24","current":-5.260132,"twenty":-10.517006,"median":-8.800328,"eighty":-7.80442,"marketCap":705089170}],"updateTime":1774470479879},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612424818","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 下午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612424818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612424818?lang=zh_cn&edition=fundamental","pubTime":"2026-02-19 03:45","pubTimestamp":1771443943,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日03时45分,Bridgebio Oncology Therapeutics, Inc.股票出现异动,股价大幅拉升5.11%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Bridgebio Oncology Therapeutics, Inc.公司简介:BridgeBio Oncology Therapeutics Inc,前身为BridgeBio Oncology Therapeutics,是一家临床阶段生物技术公司,旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BBOT","BK4539","LENZ"],"gpt_icon":0},{"id":"2610861466","title":"美国研究综述-KKR、Sirius XM、Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2610861466","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610861466?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 15:59","pubTimestamp":1770710372,"startTime":"0","endTime":"0","summary":"美国研究综述-KKR、Sirius XM、Workday路透2月10日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 KKR、Sirius XM Holdings Inc 和 Workday Inc。要点 * KKR & CO Inc KKR.N:杰富瑞将目标价从167美元下调至132美元 * Sirius XM Holdings Inc SIRI.O:摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL4S3Z60LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPG","BX","CELC","CGEM","KKR","WAT","FTAI","EXE","RAL","GPOR","DT","CAH","FANG","PANW","ZYME","WDAY","MNST","ON","BAM","GTM","AMKR","CRCL","COR","CMS","ICHR","VTR","MNSH","APA","SIRI","TPR","VCTR","BBOT","EXEL","ARVN","AES","NUVL","BN","DVN","ARES","GPI","COGT","RGNX","APO","FLNC","BDX","KD","GLTO","MCK","UPWK","AFG"],"gpt_icon":0},{"id":"2609273953","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609273953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609273953?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 01:44","pubTimestamp":1770227099,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日01时44分,Bridgebio Oncology Therapeutics, Inc.股票出现波动,股价快速下跌5.01%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Bridgebio Oncology Therapeutics, Inc.公司简介:BridgeBio Oncology Therapeutics Inc,前身为BridgeBio Oncology Therapeutics,是一家临床阶段生物技术公司,旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020501450097a4e619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020501450097a4e619&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BBOT","BK4539"],"gpt_icon":0},{"id":"2603652421","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 大幅跳水5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603652421?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 01:36","pubTimestamp":1768325779,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日01时36分,Bridgebio Oncology Therapeutics, Inc.股票出现异动,股价急速跳水5.76%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Bridgebio Oncology Therapeutics, Inc.公司简介:BridgeBio Oncology Therapeutics Inc,前身为BridgeBio Oncology Therapeutics,是一家临床阶段生物技术公司,旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011401361997a1aabc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011401361997a1aabc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BBOT","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2602581559","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 股价大涨5.08%报13.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602581559?lang=zh_cn&edition=fundamental","pubTime":"2026-01-09 22:42","pubTimestamp":1767969756,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时42分,Bridgebio Oncology Therapeutics, Inc.股票出现异动,股价快速拉升5.08%。截至发稿,该股报13.98美元/股,成交量3.2084万股,换手率0.04%,振幅3.98%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.00%。Bridgebio Oncology Therapeutics, Inc.公司简介:BridgeBio Oncology Therapeutics Inc,前身为BridgeBio Oncology Therapeutics,是一家临床阶段生物技术公司,旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BBOT","BK4139"],"gpt_icon":0},{"id":"1177500486","title":"BridgeBio Oncology Therapeutics公布三项创新Ras与Pi3kΑ研发项目临床数据取得新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1177500486","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177500486?lang=zh_cn&edition=fundamental","pubTime":"2026-01-07 20:05","pubTimestamp":1767787503,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics公司近日宣布,其三项具备创新性与差异化的Ras及Pi3kΑ管线项目临床研究数据获得显著进展。此次公布的数据进一步验证了公司在肿瘤靶向治疗领域的研发实力,为后续临床试验及潜在疗法开发奠定基础。此次数据更新将推动管线项目向更高阶段的临床研究迈进,为患者提供更具针对性的治疗选择。公司表示将继续与监管机构保持沟通,加速创新疗法的转化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"gpt_icon":0},{"id":"1188895298","title":"Bbot在圣安东尼奥乳腺癌研讨会上发布关于Bbo-10203的最新预临床数据,这是一款首创的Ras:Pi3kΑ抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1188895298","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188895298?lang=zh_cn&edition=fundamental","pubTime":"2025-12-11 05:06","pubTimestamp":1765400809,"startTime":"0","endTime":"0","summary":"Bbot在圣安东尼奥乳腺癌研讨会上发布关于Bbo-10203的最新预临床数据,这是一款首创的Ras:Pi3kΑ抑制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}